Author

S. Chau

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

A.-C. Gingras· 2 shared K. Colwill· 2 shared P. Budylowski· 2 shared R. Law· 2 shared A. Azhieh· 1 shared A. Banerjee· 1 shared A. Imran· 1 shared A. J. Diao· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A.-C. Gingras

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Immunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV

V. A. Matveev, E. Z. Mihelic, E. Benko, P. Budylowski, S. Grocott, T. Lee, C. S. Korosec, K. Colwill, H. Stephenson, R. Law, L. A. Ward, S. Sheikh-Mohamed, G. Mailhot, M. Delgado-Brand, A. Pasculescu, , M. Ostrowski

This study evaluates the immunogenicity of COVID-19 vaccines in older people with HIV and their impact on HIV reservoirs, finding that three doses are needed for optimal neutralizing responses but vaccines may increase HIV reservoirs in those with persistent viremia.

bioRxiv · Jun 14, 2023Immunology

Diverse innate immune factors protect yeast from lethal viral pathogenesis

S. Chau, J. Gao, A. J. Diao, S. B. Cao, A. Azhieh, A. R. Davidson, M. D. Meneghini

This study identifies conserved antiviral systems in yeast by showing that innate immune factors prevent lethal viral pathogenesis caused by the endogenous L-A virus.

bioRxiv · Feb 14, 2022 · PreprintMicrobiology

Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B

J. Liu, P. Budylowski, R. Samson, B. D. Griffin, G. Babuadze, B. Rathod, K. Colwill, J. A. Abioye, J. A. Schwartz, R. Law, L. Yip, S. K. Ahn, S. Chau, M. Naghibosadat, Y. Arita, , M. A. Ostrowski

This paper evaluates a SARS-CoV-2 mRNA vaccine, PTX-COVID19-B, showing it is safe, effective, and induces strong immune responses in mice and hamsters, with ongoing human clinical trials.

bioRxiv · May 11, 2021Immunology